Trial Profile
A Pan-PPAR Agonist Treatment for Bipolar Depression: A Proof of Concept Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2023
Price :
$35
*
At a glance
- Drugs Bezafibrate (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Proof of concept; Therapeutic Use
- 30 Nov 2021 Planned End Date changed from 1 Jun 2020 to 1 Jun 2023.
- 30 Nov 2021 Planned primary completion date changed from 1 Feb 2020 to 1 Feb 2023.
- 04 Dec 2019 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.